YK-1005

N/A

Report date: 2025/06/04 11:51:20
NME

Base Information

Drug NameYK-1005
Drug Alias NameYK-1005YK1005
ClassificationSmall molecules
Mechanisms of ActionSrc homology phosphotyrosyl phosphatase 2 modulators
TargetsSrc homology phosphotyrosyl phosphatase 2
Therapy Area/IndicationsLung NeoplasmsLiver NeoplasmsStomach Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesYaokang Zhongtuo (Beijing) Pharmaceutical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesYaokang Zhongtuo (Beijing) Pharmaceutical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsLiver NeoplasmsStomach Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A